Currently predicting for Mon, 1 Apr 2024

Trading levels for AVXL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.30 4.74 %
R2 5.18 2.40 %
R1 5.11 0.96 %
Current price: 5.06
Support S1 4.87 -3.72 %
S2 4.80 -5.17 %
S3 4.68 -7.51 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.05 19.47 %
R2 6.01 18.77 %
R1 5.11 0.99 %
Current price 5.06
Support S1 5.01 -0.99%
S2 4.98 -1.58%
S3 4.84 -4.35%

AVXL Predictions History

3 years ago
JS predicted that AVXL for 2021-02-05 is going $14.00 (12.99%)

3 years ago
Zwj Ephram predicted that AVXL for 2021-02-05 is going $25.00 (101.78%)

Rank:

3 years ago
JS predicted that AVXL for 2020-11-09 is going $5.41 (10.18%)

3 years ago
K122858 predicted that AVXL for 2020-11-09 is going $4.40 (-10.39%)

Rank:

4 years ago
JS predicted that AVXL for 2020-03-06 is going $4.13 (1.23%)

4 years ago
Coolman Mei predicted that AVXL for 2020-03-06 is going

Rank:

4 years ago
2poJeff predicted that AVXL for 2020-02-06 is going $3.63 (-3.97%)

4 years ago
Thomas Santucci predicted that AVXL for 2020-02-06 is going $3.90 (3.17%)

Rank:

4 years ago
AlexBo predicted that AVXL for 2019-05-15 is going $3.24 (-6.09%)

Rank:

4 years ago
NameNotImportant predicted that AVXL for 2019-05-06 is going $3.23 (2.54%)

Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT